Open Access. Powered by Scholars. Published by Universities.®

Medicine and Health Sciences Commons

Open Access. Powered by Scholars. Published by Universities.®

OncoLog MD Anderson's Report to Physicians (All issues)

Lymphedema

Articles 1 - 5 of 5

Full-Text Articles in Medicine and Health Sciences

Oncolog, Volume 61, Number 09, September 2016, Jill Delsigne-Russell, Brandon C. Strubberg, E Nielsen Sep 2016

Oncolog, Volume 61, Number 09, September 2016, Jill Delsigne-Russell, Brandon C. Strubberg, E Nielsen

OncoLog MD Anderson's Report to Physicians (All issues)

  • Transport Oncophysics Could Guide Pancreatic Cancer Treatment: Pancreatic ductal adenocarcinomas respond poorly to standard treatments. Researchers at The University of Texas MD Anderson Cancer Center are applying the principles of physics to characterize the tumors, and these analyses could lead to individualized therapy.
  • Nivolumab Shows Potential in Treating Squamous Cell Carcinoma of the Anal Canal: Currently, there are no standard therapy options for patients with treatment-refractory metastatic squamous cell carcinoma of the anal canal (SCCA), but early results of a multi-institutional clinical trial (No. NCI9673) led by researchers at The University of Texas MD Anderson Cancer Center show that the …


Oncolog, Volume 60, Number 10, October 2015, Joe Munch, Bryan Tutt, Jill Deisigne, K. Nair Oct 2015

Oncolog, Volume 60, Number 10, October 2015, Joe Munch, Bryan Tutt, Jill Deisigne, K. Nair

OncoLog MD Anderson's Report to Physicians (All issues)

  • New Targeted Therapy Offers Hope to Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm, Related Diseases: The treatment of common hematological malignancies is based on reams of study data and years of physician experience with the diseases. But such information is often limited for rare, little-researched blood cancers like blastic plasmacytoid dendritic cell neoplasm (BPDCN). This situation may soon change, thanks to the discovery of a new molecular target, which has led to a spate of innovative treatment approaches and the first dedicated clinical trials for this uncommon malignancy.
  • Laparoscopic Free Omental Lymphatic Flap Transfers Offer a Powerful Alternative for Lymphedema …


Oncolog, Volume 59, Number 06, June 2014, Jill Deisigne, Luanne Jorewicz, K. Stuyck Jun 2014

Oncolog, Volume 59, Number 06, June 2014, Jill Deisigne, Luanne Jorewicz, K. Stuyck

OncoLog MD Anderson's Report to Physicians (All issues)

  • New Agents Hold Promise for Patients With Advanced Thyroid Cancer: New agents are expanding treatment options for patients with advanced thyroid cancer-not only the papillary variant but also the less common medullary and differentiated variants of the disease
  • Surgical Options for Lymphedema: Lymphedema of the extremities, whether from cancer treatment or other causes, typically is not curable. But advances in surgical techniques are reducing or eliminating symptoms for many patients
  • INBRIEF: Intensity-Modulated Radiation Therapy Improves Survival in Head and Neck Cancer Patients/ Research Findings Could Lead to Blood Test for Cancer-Related Gene Defects/ Tumor-Suppressing Protein May Help Predict Survival in …


Oncolog Volume 54, Number 06, June 2009, John Lebas, Maude Veech Jun 2009

Oncolog Volume 54, Number 06, June 2009, John Lebas, Maude Veech

OncoLog MD Anderson's Report to Physicians (All issues)

  • Chronic Myelogenous Leukemia: Refining Approaches to Treatment
  • Advancing the Treatment of Lymphedema
  • House Call: Hospice: Comforting Care When the End Is Near


Oncolog, Volume 41, Number 02, April-June 1996, Kathryn L. Hale, Stephanie P. Deming Jan 1996

Oncolog, Volume 41, Number 02, April-June 1996, Kathryn L. Hale, Stephanie P. Deming

OncoLog MD Anderson's Report to Physicians (All issues)

  • lntraoperative lymphatic mapping elegant way to identify lymph node metastases in melanoma patients
  • New Patient Referral Office changes with M. D. Anderson's referral policy
  • Combined chemotherapy and radiation therapy bringing hope for inoperable lung cancer